Ameriprise
XTNT icon

Ameriprise’s Xtant Medical Holdings XTNT Stock Holding History

Ameriprise’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7
Closed – – 4456
2014
Q3 		$0 Hold
7
– – ﹤0.01% 5908
2014
Q2 		$1K Hold
7
– – ﹤0.01% 5387
2014
Q1 		$1K Hold
7
– – ﹤0.01% 5197
2013
Q4 		$0 Hold
7
– – ﹤0.01% 5432
2013
Q3 		$1K Hold
7
– – ﹤0.01% 5509
2013
Q2 		$0 Buy
+7
New +$579 ﹤0.01% 5581

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GCM
Goldman Capital Management New York $103M AUM 21.37% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
OA
Outfitter Advisors Mclean, Virginia $221M AUM 13.61% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameriprise's XTNT Position: Q4 2014 in Review

Ameriprise sold out of Xtant Medical Holdings (XTNT) in Q4 2014, closing a stake of 7 shares.

Ameriprise first reported a position in XTNT in Q2 2013 and held it in 6 quarters. The position peaked at $1K in Q2 2014. 17 funds tracked by Wall St. Rank hold XTNT as of Q4 2014.

  • Ameriprise reported no remaining Xtant Medical Holdings position as of Q4 2014 after selling out during the quarter.
  • Ameriprise sold 7 Xtant Medical Holdings shares in Q4 2014.
  • Ameriprise first reported a position in Xtant Medical Holdings in Q2 2013 and held it in 6 quarters.
  • Ameriprise's Xtant Medical Holdings position peaked at $1K in Q2 2014.
  • 17 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2014.

Based on Ameriprise's 13F filing for Q4 2014, filed 13 Feb 2015.